COVID-19: For information related to COVID-19 (formerly referred to as “novel coronavirus"), visit

VCU Massey Cancer Center


2017 Archive

May 2017

Massey radiation oncologist Emma Fields honored with Educator of the Year award

Massey radiation oncologist Emma Fields, M.D., was recognized on May 1, 2017, as VCU Health’s Educator of the Year by the Association of Residents in Radiation Oncology (ARRO) for her excellence in teaching and enthusiastic support of residency training.

Continue reading →

Massey doctors first in the world to use internal radiation implant to treat pancreatic cancer

Doctors at VCU Massey Cancer Center in Richmond, Virginia are the first in the world to successfully implant a bio-absorbable, internal radiation device known as CivaSheet to treat early stage pancreatic cancer.

Continue reading →

Chen, Zhijian

Massey neuro-oncologist answers questions about chemotherapy-induced peripheral neuropathy

May 7-13 is National Neuropathy Awareness Week. Peripheral neuropathy, often simply referred to as “neuropathy,” is a condition that occurs when your peripheral nerves, the nerves that transmit signals between your central nervous system and the rest of your body, become damaged or disrupted. Many cancer patients experience a form of neuropathy called chemotherapy-induced peripheral neuropathy (CIPN). In this Q&A, Zhijian Chen, M.D., Ph.D., a neuro-oncologist at VCU Massey Cancer Center, explains CIPN, what causes it and what can be done to treat it. 

Continue reading →

Study of head and neck cancer data from The Cancer Genome Atlas redefines HPV-related cancers

Much of what we thought we knew about the human papillomavirus (HPV) in HPV-related head and neck cancers may be wrong, according to a newly published study by Virginia Commonwealth University (VCU) researchers that analyzed data from The Human Cancer Genome Atlas. Head and neck cancers involving HPV are on the rise, and many experts believe we are seeing the start of an epidemic that will only get worse in the coming years.  

Continue reading →

Massey pulmonologist hopes to develop blood-based tests for early detection of lung cancer

Massey pulmonologist and cancer researcher Patrick Nana-Sinkam, M.D., F.C.C.P., studies genetic biomarkers as a means of developing novel blood-based tests for the early detection of lung cancer and potentially improving overall patient outcomes through the use of new targeted therapies. Nana-Sinkam joined VCU Massey Cancer Center as a member of the Cancer Cell Signaling and Cancer Prevention and Control research programs in September 2016. He also serves as chair of and professor in the Division of Pulmonary Disease and Critical Care Medicine of the Department of Internal Medicine at the VCU School of Medicine. 

Continue reading →